The Office of National Drug Control Policy was established in the year 1998 by the Anti- Drug Abuse Act.  The Office of National Drug Control Policy establishes policies, priorities, and objectives for the Nation’s drug control program.  The program aims to reduce illicit drug use, manufacturing, trafficking, drug-related crime and violence, and drug-related health consequences in the United States.  Formerly, the White House Office of National Drug Control Policy (ONDCP) was a cabinet level unit of the Executive Office of the President of the United States.

Generally, the office of the Director of ONDCP is known as the “Drug Czar.”  The Director of ONDCP evaluates, synchronizes, and manages the international and domestic anti-drug activities of executive branch agencies.

The Director recommends to the President changes to be implemented in the organization, management and budgeting.  He advises the personnel of federal agencies to monitor the effect of the United States anti drug efforts.  The Director also checks the federal agency’s conformity with their obligations under the National Drug Control Strategy and prepares an annual report prescribed by law.